In this study, we aim to map the frequency and predictors of SSRI induced sexual dysfunction and determine if serotonergic tonus (measured by 5-HT4R PET binding) pre-treatment, or changes in response to SRRI treatment, is associated with sexual desire and/or development of SSRI-induced sexual dysfunction in MDD. The gene discussed is HTR4; the disease is major depressive disorder.